Sustained response to lenvatinib and pembrolizumab in two patients with KRAS-mutated endometrial mesonephric-like adenocarcinoma

Affiliations

Sherry Shen: Corresponding author at: 1275 York Avenue Box 8, New York, NY 10065, United States.; Memorial Sloan Kettering Cancer Center, New York, NY, United States
Maria M. Rubinstein: Memorial Sloan Kettering Cancer Center, New York, NY, United States
Kay J. Park: Memorial Sloan Kettering Cancer Center, New York, NY, United States
Jason A. Konner: Memorial Sloan Kettering Cancer Center, New York, NY, United States
Vicky Makker: Memorial Sloan Kettering Cancer Center, New York, NY, United States

Abstract

No abstracts available.

ISSN: 2352-5789 (Online)
Publisher: Elsevier
Country of publisher: United States
LCC subjects: Medicine: Gynecology and obstetrics; Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.sciencedirect.com/journal/gynecologic-oncology-reports